These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749 [No Abstract] [Full Text] [Related]
8. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol. Arora N; Sandroni S; Moles K Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854 [TBL] [Abstract][Full Text] [Related]
9. Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis. Memmos DE; Eastwood JB; Talner LB; Gower PE; Curtis JR; Phillips ME; Carter GD; Alaghband-Zadeh J; Roberts AP; de Wardener HE Br Med J (Clin Res Ed); 1981 Jun; 282(6280):1919-24. PubMed ID: 6786673 [TBL] [Abstract][Full Text] [Related]
10. Long-term therapy of uremic osteodystrophy in adults with calcitriol. Moorthy AV; Harrington AR; Mazess RB; Simpson DP Clin Nephrol; 1981 Aug; 16(2):93-100. PubMed ID: 6894893 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of renal osteodystrophy with calcitriol in patients on maintenance haemodialysis]. Tomanovski V Srp Arh Celok Lek; 1994; 122(5-6):136-8. PubMed ID: 17977409 [TBL] [Abstract][Full Text] [Related]
12. Calcitriol oral pulse therapy in children with renal osteodystrophy. Cano F; Delucchi A; Wolff E; Rodriguez E; Fuentes A Pediatr Nephrol; 1995 Oct; 9(5):606-8. PubMed ID: 8580020 [TBL] [Abstract][Full Text] [Related]
13. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol. Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585 [TBL] [Abstract][Full Text] [Related]
14. [Estimation of the prevalence of low turn over renal osteodystrophy using biological markers in a peritoneal dialysis population]. Negri AL; Alvarez Quiroga M; Bravo M; Fradinger E; Jacobo de Marino A; Bogado CE; Zanchetta JR Nefrologia; 2001; 21(4):392-4. PubMed ID: 11816516 [No Abstract] [Full Text] [Related]
15. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment. Lye WC; Lee EJ Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414 [TBL] [Abstract][Full Text] [Related]
16. "High-dose" calcitriol for control of renal osteodystrophy in children on CAPD. Salusky IB; Fine RN; Kangarloo H; Gold R; Paunier L; Goodman WG; Brill JE; Gilli G; Slatopolsky E; Coburn JW Kidney Int; 1987 Jul; 32(1):89-95. PubMed ID: 3626302 [TBL] [Abstract][Full Text] [Related]
17. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. Coen G; Mazzaferro S; Ballanti P; Bonucci E J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330 [No Abstract] [Full Text] [Related]
18. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT. Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182 [No Abstract] [Full Text] [Related]
19. [Course and significance of various biochemical parameters in 1,25-dihydroxyvitamin D3 therapy of uremic osteodystrophy]. Giachino G; Giacchino F; Basolo B; Giraudo G; Boero R; Bancale E; Nigra M; Garetto A; Jeantet A; Piccoli G Arch Sci Med (Torino); 1983; 140(3):259-66. PubMed ID: 6689545 [TBL] [Abstract][Full Text] [Related]
20. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Lee SH; Huang TS; Hsieh SJ Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]